Asher Biotherapeutics’ $108 Million Series B Financing

Goodwin Procter advised Asher Biotherapeutics on the deal.Asher Biotherapeutics announced the closing of its Series B financing, which raised $108 million. The financing was led by Wellington…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here